EORTC Breast Cancer Group Autumn Meeting

Brussels, BE

The EORTC Breast Cancer Group meeting will be held on 14 and 15 October in Brussels, Belgium (face-to-face meeting) and is only open to individual or site staff members of the group.
Registrations for the meeting are now closed. Please send an email to if you would still like to attend.


Institut Jules Bordet
Rue Meylemeersch, 90
1070 Anderlecht

For accessibility click here


Below is the agenda overview:

Friday 14 October

09:00|09:45 EORTC Breast Cancer Group Steering Committee (closed session)
09:45|10:00 Coffee break
10:00|11:30 Academic Research in Europe (open session)
Welcome & Introduction
Michail Ignatiadis, EORTC Breast Cancer Group Chair
Welcome speeches
Dirk Van Gestel, Deputy Medical Director – Institut Jules Bordet
How Molecular Oncology Influences Academic Research,
the experience of Oncodistinct Network
Ahmad Awada, Oncology Medicine Department Chair – Institut Jules Bordet
EORTC and Cancer Medicine Forum
Denis Lacombe, CEO – EORTC
Breast International Group and lessons learned for academic research
Martine Piccart, Scientific Director – Institut Jules Bordet
11:30|12:30 Visit New Bordet
12:30|13:00 Reception
13:00|14:00 Lunch
14:00|16:15 General topics (closed session)
Update from EORTC Breast Cancer Group Steering Committee Retreat
Michail Ignatiadis / Frederieke van Duijnhoven / Monica Arnedos
Master protocol of Preoperative Treatment for TNBC patients with residual disease after completion of neoadjuvant treatment: a window of opportunity study
Gustavo Werutsky
Feedback from the ROSC
Enrico Clementel
Update from EORTC Scientific Chairs Council
Michail Ignatiadis
Social media coverage for BCG
Michail Ignatiadis
Spring BCG Meeting
Michail Ignatiadis
Michail Ignatiadis
Feedback from the Older Adult Patients Task Force
Etienne Brain
Current scenario of breast cancer in Latin America and opportunities for intergroup clinical trials
Gustavo Werutsky
Update on EORTC IDMC Policy and SOP
C. Ponce
16:15|16:30 Coffee break
16:30|17:30 Panel discussion: Young oncologists activity in BCG
Ann Marinus, Michail Ignatiadis, Frederieke van Duijnhoven, Monica Arnedos and the young oncologists
19:30|22:00 Dinner at Restaurant La Quincaillerie (45, Rue du Page, 1050 Bruxelles)

Saturday 15 October

09:00|10:00 General update working groups (closed session)
Elderly patients
Etienne Brain
Locoregional disease
Frederieke van Duijhoven
New treatments
Michail Ignatiadis
POST ASCO 2022 and Post ESMO 2022 Updates
Open Discussion for BCG Studies in Areas of Unmet Medical Need (ALL)
Proposals and studies in pre-development (closed session)
Improvement of Quality of Life through supportive treatments for hormone therapy
K. Pogoda
10:00|10:15 Coffee break
10:15|12:30 Proposals and studies in pre-development (closed session) continued
2203 – Tax trial
E. Brain
1984 – Olaparib and durvalumab as neoadjuvant therapy
E. Brain
2129 – Elacestrant for treating ER+/HER2
M. Ignatiadis
10:15|12:30 Ongoing trials (closed session)
1965 – De-escalation of adjuvant chemotherapy in HER2
E. Brain
2033 – A randomized, multicenter, double-blind phase 3 study of SAR439859
E. Brain
1745 – Palbociclib in elderly patients
H. Wildiers
12:30|14:00 Lunch



We advise you the following hotels for which you can get preferential rates.
You can download the forms hereunder and directly book the hotel of your choice.
The Hotel ( – Booking form The Hotel
Motel One ( – Booking form Motel One

Next events

  • The 10+1 Santorini Conference


  • EACR Annual Congress 2024

    Rotterdam, Netherlands

  • Clinical Trial Statistics for Non-Statisticians

    Brussels, BE

  • EORTC Leukemia Group Spring Meeting 2024

    Madrid, ES

  • 24th Workshop on Methods in Clinical Cancer Research (MCCR)

    Sint Michielgestel, Netherlands